Ashland Inc. — Cyborg Score 6/10

Solid
Specialty Chemicals

Strategic Profile

The company projects continued momentum in innovation-driven and globalized product lines. Ashland recently hosted an Innovation Day showcasing enhanced capabilities and expanded applications of scalable technology platforms across Life Sciences, Personal Care, and Specialty Additives.

Cyborg Score Rationale

First quarter net loss narrowed to $12 million ($0.26 per share) from $165 million in the prior year, with adjusted income from continuing operations at $0.26 per share versus $0.28 year-over-year. Full year fiscal 2026 Adjusted EBITDA guidance ranges $400-$420 million. Near-term execution challenges exist.

Top Insights

  • Four-segment portfolio (Life Sciences, Personal Care, Specialty Additives, Intermediates) provides diversified exposure across pharma, personal care, industrial coatings, and chemical intermediates
  • Recent losses from Avoca divestiture and Calvert City startup delays indicate portfolio optimization and capacity expansion investments
  • FY2026 revenue guidance of $1.835B-$1.905B reflects modest 1-3% organic growth despite temporary operational disruptions
  • Recent Innovation Day emphasis on scalable platforms and expanded applications suggests focus on high-margin, innovation-driven growth

Named Competitors

  • Specialty Chemicals — Diversified specialty chemicals and polyurethanes
  • Performance Materials — Advanced engineered materials and chemical specialties
  • Specialty Chemicals & Lithium — Catalysts, lithium, and fine chemicals

Recent Developments

  • (March 2026) Quarterly cash dividend of $0.415 per share declared
  • (February 2026) Q1 FY2026 net loss narrowed to $12M; full-year EBITDA guidance narrowed to $400-420M due to Calvert City startup delays
  • (October 2025) Expanded pharmaceutical excipient portfolio with high purity sucrose and parenteral applications
  • (October 2025) New Director of Investor Relations appointed (Sandy Klugman)

Open the full interactive Ashland Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →